Oxaliplatin and capecitabine (Xelox) in association with highly active antiretroviral therapy in advanced hepatocarcinoma HIV/HCV-infected patients [5]

Annals of Oncology

Volumn 17, Issue 7, 2006, Pages 1176-1177

  Berretta, M ^a   Lleshi, A ^a   Di Benedetto, F ^b   Bearz, A ^a   Spina, M ^a   Tirelli, U ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTIRETROVIRUS AGENT; CAPECITABINE; OXALIPLATIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; XELOX;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ADVANCED CANCER; BLOOD CELL COUNT; BLOOD TOXICITY; CANCER GROWTH; CANCER REGRESSION; CANCER STAGING; CASE REPORT; CAUSE OF DEATH; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DEATH; DIGESTIVE SYSTEM CANCER; DRUG DOSE REGIMEN; DRUG POTENTIATION; ELECTROCARDIOGRAM; FEMALE; GASTROINTESTINAL TOXICITY; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LETTER; LIFE EXPECTANCY; LIVER CELL CARCINOMA; LYMPHOCYTE COUNT; MALE; MORBIDITY; MORTALITY; OPPORTUNISTIC INFECTION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; VIRUS LOAD;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CARCINOMA, HEPATOCELLULAR; DEOXYCYTIDINE; DRUG THERAPY, COMBINATION; FEMALE; FLUOROURACIL; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PRODRUGS;

EID: 33745620471     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdj140     Document Type: Letter

References (5)

1. Bonnet F, Lewden C, May T et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 2004; 101: 317-24.
2. Puoti M, Bruno R, Soriano V et al. Hepatocellular carcinoma in HIV-infected patients: Epidemiological features, clinical presentation and outcome. AIDS 2004; 18: 2285-93.
3. Cerosimo RJ. Oxaliplatin-associated neuropathy: A review. Ann Pharmacother 2005; 39: 128-35.
4. Patt YZ, Hassan MM, Aguayo A et al. Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma. Cancer 2003; 101: 578-86.
5. Jatoi A, Murphy BR, Foster NR et al. Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroensophageal junction and gastric cardia: A phase II study from the North Central Cancer Treatment Group. Ann Oncol 2006; 17: 29-34.